Next Article in Journal
6,10-Dichloro-1-oxa-4,8-dithia-7,9-diazaspiro[4.5]deca-6,9-diene
Previous Article in Journal
(E)-3-[4-(1H-Imidazol-1-yl)phenyl]-1-(3-chloro-4-fluorophenyl)prop-2-en-1-one
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

N-(2-Benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide

1
Department of General and Inorganic Chemistry with Methodology of Chemistry Education, Faculty of Chemistry, University of Plovdiv “Paisii Hilendarski”, 24, Tzar Asen Str., 4000 Plovdiv, Bulgaria
2
Department of Organic Chemistry, Faculty of Chemistry, University of Plovdiv “Paisii Hilendarski”, 24, Tzar Asen Str., 4000 Plovdiv, Bulgaria
3
Department of Inorganic Chemistry, Faculty of Chemistry, Gdansk University of Technology, G. Narutowicza 11/12, 80-233 Gdansk, Poland
4
Faculty of Chemistry and Pharmacy, Sofia University, 1, J. Bourchier Av., 1164 Sofia, Bulgaria
*
Author to whom correspondence should be addressed.
Molbank 2022, 2022(2), M1376; https://doi.org/10.3390/M1376
Submission received: 9 May 2022 / Revised: 27 May 2022 / Accepted: 27 May 2022 / Published: 1 June 2022

Abstract

:
The crystal structure of N-(2-benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide indicates that the compound crystallizes in the monoclinic C2/c space group with eight molecules in the unit cell. The heteroatoms from the amide group form a chain of intermolecular N-H ··· O hydrogen bonds propagating along the b axis. The carbonyl group from the benzoyl substituent participates in short contacts with two H-atoms from the ethyl or phenyl groups.

Graphical Abstract

1. Introduction

The title compound was synthesized as a precursor for the synthesis of a series of differently substituted 1,2,3,4-tetrahydroisoquinolines and its molecular structure (Figure 1) was described on the basis of spectroscopic data (IR, 1H and 13C NMR) [1]. Besides their use as synthetic scaffolds, 2-phenylacetamides are also known for their application in medicinal chemistry as they possess a variety of biological activities depending on the structural features of the substituents. Their anticonvulsant [2], antidepressant [3] and antiproliferative [4] activities are only a few to mention. Herein, we report the crystal structure of N-(2-benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide obtained by single-crystal X-ray diffraction analysis. The presence of suitable coordination groups in the studied ketoamide have provoked systemic study on its coordination properties and some data have recently been published [5]. The data showed that complexation with metal ions is strongly ruled by the coordination ability of the used metal ion. This could be explained with the conformational flexibility of the title compound and its intrinsic ability to form various types of intermolecular hydrogen bonding. In this short note, we provide data on these structural features as observed in the crystal packing.

2. Results

The studied ketoamide compound crystallizes in the monoclinic C2/c space group. The structure of the asymmetric unit is depicted in Figure 2, along with the atom numbering. All three aromatic rings in the molecule are almost orthogonal to each other. The unit cell contains eight molecules and is depicted in Figure 3, where the short contacts between the C-H and C-O groups from adjacent molecules are highlighted. All oxygen atoms participate in the formation of short contacts, whereas the C=O and N-H from the amide group participate in the formation of an intermolecular hydrogen-bonding chain. The propagation of this chain is shown in Figure 4, and the structural features of all hydrogen bonds are summarized in Table 1.
The title compound has previously been studied for its complexation ability with metal ions (Pd(II) and Zn(II)) and detailed spectroscopic data have been provided [5]. The crystal structure described herein corroborates with the findings from IR, Raman and NMR spectroscopies. The earlier reported IR stretching vibration for the carbonyl groups with frequencies lower than 1700 cm−1 (namely 1662 cm−1 for the C=O from the keto group and 1652 cm−1 for the C=O from the amide group [5]) may suggest that these groups are engaged in moderate intermolecular hydrogen bonding in the solid state, as evidenced by the crystal structure described here.
In summary, the crystal structure of the studied ketoamide reveals the participation of all oxygen atoms in the formation of either intermolecular hydrogen bonding of C=O…H-N type or short contacts with the C-H groups. The latter are CH---π interactions and are quite common in systems featuring aromatic rings. Positively charged hydrogen atoms willingly interact with the electron densities above and below the planes of aromatic rings and are part of Van der Waals interactions.

3. Experimental Section

Good quality single crystals from the title compound were obtained from DMSO-d6 solution in an NMR tube after 1 month of slow evaporation. Yellow prisms with 0.54 × 0.26 × 0.11 mm were analyzed on a 2-circle diffractometer STOE IPDS 2T using GeniX Mo, 0.05 × 0.05 mm2 microfocus as a source for monochromated MoKα radiation (λ = 0.71073 Å) at 120(2) K. Crystal data, data collection and structure refinement details are summarized in Table 2.
The diffraction data were corrected for absorption effects by the Gaussian integration method implemented in the STOE X-Red32 software. Unit cell parameters were calculated and refined from the full data set. The structures were solved by a full-matrix least squares procedure based on F2 using the SHELX–2014 program package [6], implemented in the Olex [7] and Wingx [8] suites of programs. All non-hydrogen atoms were refined anisotropically, and the positions of the hydrogen atoms were either calculated using a riding model in isotropic approximation or deduced from the electron density map (N-H1). The crystal data have been deposited at the Cambridge Crystallographic Data Centre as CCDC 2157168. (Supplementary Materials). The data can be obtained free of charge from the Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/getstructures. Complete structural parameters for the title compound are listed in Table S1 in the Supplementary Materials along with the 1H and 13C NMR spectra.

Supplementary Materials

The following supporting information can be downloaded online; Table S1: Geometric parameters (bond lengths in Å, and angles in º) for N-(2-benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide, along with the cif and check-cif files. 1H and 13C NMR spectra are given in Figures S1 and S2, respectively.

Author Contributions

P.M. and S.N. prepared the compound; A.D. collected the X-ray data and solved the structure; P.M. and S.N. designed the study; A.A. analyzed the data and wrote the paper. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The X-ray data are available at CCDC under ref. code CCDC 2157168.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compound are not available.

References

  1. Ivanov, I.; Nikolova, S.; Aladjov, D.; Stefanova, I.; Zagorchev, P. Synthesis and Contractile Activity of Substituted 1,2,3,4-Tetrahydroisoquinolines. Molecules 2011, 16, 7019–7042. [Google Scholar] [CrossRef] [PubMed]
  2. Shindikar, A.V.; Viswanathan, C.L. Substituted 2-[2-(pyridin-3-yl) phenyl] acetamides and ureas: Design, synthesis, and anticonvulsant screening in mice. Med. Chem. Res. 2012, 21, 1929–1934. [Google Scholar] [CrossRef]
  3. Shelke, S.M.; Bhosale, S.H. Synthesis, antidepressant evaluation and QSAR studies of novel 2-(5H-[1, 2, 4] triazino [5, 6-b] indol-3-ylthio)-N-(substituted phenyl) acetamides. Bioorg. Med. Chem. Lett. 2010, 20, 4661–4664. [Google Scholar] [CrossRef] [PubMed]
  4. Chen, I.L.; Chen, J.J.; Lin, Y.C.; Peng, C.T.; Juang, S.H.; Wang, T.C. Synthesis and antiproliferative activities of N-(naphthalen-2-yl)acetamide and N-(substituted phenyl)acetamide bearing quinolin-2(1H)- one and 3,4-dihydroquinolin-2(1H)-one derivatives. Eur. J. Med. Chem. 2013, 59, 227–234. [Google Scholar] [CrossRef] [PubMed]
  5. Marinova, P.E.; Tsoneva, S.H.; Nikolova, S.A.; Ivanov, I.I. Novel complexes of N-substituted-4,5-dimethoxy-phenylethyl-2-arylketoamides with metal ions. Bulg. Chem. Commun. 2019, 51, 8–11. [Google Scholar]
  6. Sheldrick, G.M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. Sect. C 2015, 71, 3–8. [Google Scholar] [CrossRef] [PubMed]
  7. Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H. OLEX2: A complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341. [Google Scholar] [CrossRef]
  8. Farrugia, L.J. WinGX and ORTEP for Windows: An update. J. Appl. Crystallogr. 2012, 45, 849–854. [Google Scholar] [CrossRef]
Figure 1. Molecular structure of N-(2-benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide.
Figure 1. Molecular structure of N-(2-benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide.
Molbank 2022 m1376 g001
Figure 2. Crystal structure of N-(2-benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide with atoms numbering.
Figure 2. Crystal structure of N-(2-benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide with atoms numbering.
Molbank 2022 m1376 g002
Figure 3. Unit cell view along the b axis showing the short contacts of C-H…O type.
Figure 3. Unit cell view along the b axis showing the short contacts of C-H…O type.
Molbank 2022 m1376 g003
Figure 4. Chain of C=O…H-N hydrogen bonding for N-(2-benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide.
Figure 4. Chain of C=O…H-N hydrogen bonding for N-(2-benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide.
Molbank 2022 m1376 g004
Table 1. Hydrogen-bond geometry (distances in Å and angles in o) for N-(2-benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide.
Table 1. Hydrogen-bond geometry (distances in Å and angles in o) for N-(2-benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide.
D—H···AD—HH···AD···AD—H···A
N1—H1···O1 i0.844 (19)2.055 (19)2.8894 (19)169.8 (16)
C10—H10A···O40.972.392.8885 (18)111
C17—H17A···O2 ii0.962.583.438 (2)149
C17—H17C···O3 i0.962.643.444 (2)142
Symmetry codes: (i) x, y + 1, z; (ii) -x + 1/2, y + 1/2, -z + 1/2.
Table 2. Experimental details.
Table 2. Experimental details.
Crystal Data
Chemical formulaC25H25NO4
Mr403.46
Crystal system, space groupMonoclinic, C2/c
Temperature (K)120
a, b, c (Å)23.724 (9), 4.9750 (15), 35.816 (15)
b (°)103.99 (3)
V3)4102 (3)
Z8
Radiation typeMo Ka
m (mm1)0.09
Crystal size (mm)0.54 × 0.26 × 0.11
Data collection
DiffractometerSTOE IPDS 2T
Absorption correctionIntegration ; STOE X-RED32, absorption correction by Gaussian integration
Tmin, Tmax0.970, 0.993
No. of measured, independent and observed [I > 2s(I)] reflections13109, 4005, 3221
Rint0.042
(sin q/l)max1)0.617
Refinement
R[F2 > 2s(F2)], wR(F2), S0.041, 0.113, 1.05
No. of reflections4005
No. of parameters276
H-atom treatmentH atoms treated by a mixture of independent and constrained refinement
max, Dρmin (e Å3)0.26, −0.25
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Marinova, P.; Nikolova, S.; Dołęga, A.; Ahmedova, A. N-(2-Benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide. Molbank 2022, 2022, M1376. https://doi.org/10.3390/M1376

AMA Style

Marinova P, Nikolova S, Dołęga A, Ahmedova A. N-(2-Benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide. Molbank. 2022; 2022(2):M1376. https://doi.org/10.3390/M1376

Chicago/Turabian Style

Marinova, Petja, Stoyanka Nikolova, Anna Dołęga, and Anife Ahmedova. 2022. "N-(2-Benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide" Molbank 2022, no. 2: M1376. https://doi.org/10.3390/M1376

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop